Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Drugs|March 29, 2003
Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?Rob E Aarnoutse, Jonathan M Schapiro, Charles A B Boucher, et al.
AIDS (London, England)|December 31, 2008
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewWouter F W Bierman, Michiel A van Agtmael, Monique Nijhuis, et al.
Atherosclerosis|September 16, 1999
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]L Yu, E Heere-Ress, B Boucher, et al.
Presse Medicale (Paris, France : 1983)|March 7, 2002
[Silent myocardial ischemia in type 2 diabetes. Predictive value of intima-media thickness]B Boucher, A Cerisier, K Bouchou, et al.
Plos Medicine|November 9, 2006
Criteria for drugs used in pre-exposure prophylaxis trials against HIV infectionInge Derdelinckx, Mark A Wainberg, Joep M A Lange, et al.
Journal of Medical Virology|January 20, 2009
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapyJames W T Cohen Stuart, Marieke Velema, Rob Schuurman, et al.
The Journal of Infectious Diseases|July 12, 2011
Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg lossRoeland Zoutendijk, Bettina E Hansen, Anneke J van Vuuren, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 14, 2004
[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]M C A Smit, M H Haverkamp, A J L Weersink, et al.
British Journal of Neurosurgery|January 17, 2018
Multiple intracranial aneurysms in a patient with type I Gaucher disease: a case report and literature reviewMatthew R Reynolds, Daniel M Heiferman, Andrew B Boucher, et al.
Bioresource Technology|June 26, 2010
Investigation into the relationship between the gravity vector and the flow vector to improve performance in two-phase continuous flow biodiesel reactorS A Unker, M B Boucher, K R Hawley, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Drugs|March 29, 2003
Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?Rob E Aarnoutse, Jonathan M Schapiro, Charles A B Boucher, et al.
AIDS (London, England)|December 31, 2008
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewWouter F W Bierman, Michiel A van Agtmael, Monique Nijhuis, et al.
Atherosclerosis|September 16, 1999
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]L Yu, E Heere-Ress, B Boucher, et al.
Presse Medicale (Paris, France : 1983)|March 7, 2002
[Silent myocardial ischemia in type 2 diabetes. Predictive value of intima-media thickness]B Boucher, A Cerisier, K Bouchou, et al.
Plos Medicine|November 9, 2006
Criteria for drugs used in pre-exposure prophylaxis trials against HIV infectionInge Derdelinckx, Mark A Wainberg, Joep M A Lange, et al.
Journal of Medical Virology|January 20, 2009
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapyJames W T Cohen Stuart, Marieke Velema, Rob Schuurman, et al.
The Journal of Infectious Diseases|July 12, 2011
Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg lossRoeland Zoutendijk, Bettina E Hansen, Anneke J van Vuuren, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 14, 2004
[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]M C A Smit, M H Haverkamp, A J L Weersink, et al.
British Journal of Neurosurgery|January 17, 2018
Multiple intracranial aneurysms in a patient with type I Gaucher disease: a case report and literature reviewMatthew R Reynolds, Daniel M Heiferman, Andrew B Boucher, et al.
Bioresource Technology|June 26, 2010
Investigation into the relationship between the gravity vector and the flow vector to improve performance in two-phase continuous flow biodiesel reactorS A Unker, M B Boucher, K R Hawley, et al.
Pageof 18